TickerFacts.

Nephros Inc (NEPH): Operating Cash Flow

Annual figures by period end, from SEC filings.

$1.60M
Year ended 2025-12-31
2010-12-31: -$1.29M2011-12-31: -$1.30M2012-12-31: -$1.55M2013-12-31: -$3.58M2014-12-31: -$2.50M2015-12-31: -$3.81M2016-12-31: -$2.11M2017-12-31: -$77.0K2024-12-31: -$500.0K2025-12-31: $1.60M$1.60M
2010-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$1.60Mn/m2026-03-12, From 2025-01-01
2024-12-31-$500.0Kn/a2025-03-24, From 2024-01-01
No annual figure between 2017-12-31 and 2024-12-31.
2017-12-31-$77.0Kn/m2018-02-26, From 2017-01-01
2016-12-31-$2.11Mn/m2018-02-26, From 2016-01-01
2015-12-31-$3.81Mn/m2017-03-20, From 2015-01-01
2014-12-31-$2.50Mn/m2016-03-30, From 2014-01-01
2013-12-31-$3.58Mn/m2015-04-15, From 2013-01-01
2012-12-31-$1.55Mn/m2014-03-28, From 2012-01-01
2011-12-31-$1.30Mn/m2013-03-04, From 2011-01-01
2010-12-31-$1.29Mn/a2012-03-22, From 2010-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Nephros Inc (NEPH)2025-12-31$1.60Mn/m
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31-$3.93Mn/m
Spectral AI, Inc. (MDAI)2025-12-31-$9.92Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$15.26Mn/m
Profound Medical Corp. (PROF)2025-12-31-$38.21Mn/m
Biotricity Inc. (BTCY)2026-03-31-$719.0Kn/m
DarioHealth Corp. (DRIO)2025-12-31-$25.94Mn/m
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31-$1.34Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$28.95Mn/m

Compare NEPH, SNOA, MDAI, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗